RECRUITING

Economic Navigation and Strengthening to Research Unrestricted Services for Transgender Women (ENTRUST)

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The overall hypothesis is that stabilizing transgender women financially while providing them tailored counselling will increase their odds of them linking to substance use services, PrEP services if they do not have HIV, and transgender women who are living with HIV will be more adherent to their ART treatment.

Official Title

Economic Navigation and Strengthening to Research Unrestricted Services for Transgender Women (ENTRUST)

Quick Facts

Study Start:2023-07-11

Study Completion:2027-06

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT06202898

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:MALE

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* Aged ≥18 years * Male at birth * Identify as a woman/transgender woman * Should not be consistently using PrEP (less than four doses per week) * Should not have any known allergy or adverse reaction to PrEP or the active drug tenofovir in ART. One of the goals of the study is to move more people into a PrEP program * Be able to speak and understand spoken English and/or Spanish (including persons who cannot read or write) * Have a smart phone that can take pictures	* Unwilling to adhere to study procedures * Participation in an HIV vaccine trial * Have a life-threatening SUD\* * Any condition, that in the opinion of the study staff, would make participation in the study unsafe, or interfere with achieving the study objective such as medical conditions which prevents the use of PrEP * Unable to provide consent

Inclusion Criteria

Exclusion Criteria

* Aged ≥18 years
* Male at birth
* Identify as a woman/transgender woman
* Should not be consistently using PrEP (less than four doses per week)
* Should not have any known allergy or adverse reaction to PrEP or the active drug tenofovir in ART. One of the goals of the study is to move more people into a PrEP program
* Be able to speak and understand spoken English and/or Spanish (including persons who cannot read or write)
* Have a smart phone that can take pictures

* Unwilling to adhere to study procedures
* Participation in an HIV vaccine trial
* Have a life-threatening SUD\*
* Any condition, that in the opinion of the study staff, would make participation in the study unsafe, or interfere with achieving the study objective such as medical conditions which prevents the use of PrEP
* Unable to provide consent

Contacts and Locations

Study Contact

Elena Cyrus, PhD

CONTACT

4072661507

elena.cyrus@ucf.edu

Amoy Fraser, PhD, CCRP, PMP

CONTACT

4072668742

amoy.fraser@ucf.edu

Principal Investigator

Elena Cyrus, PhD

PRINCIPAL_INVESTIGATOR

University of Central Florida

Study Locations (Sites)

University of Central Florida

Orlando, Florida, 32827

United States

Collaborators and Investigators

Sponsor: University of Central Florida

Elena Cyrus, PhD, PRINCIPAL_INVESTIGATOR, University of Central Florida

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-07-11

Study Completion Date2027-06

Study Record Updates

Study Start Date2023-07-11

Study Completion Date2027-06

Terms related to this study

Additional Relevant MeSH Terms

Transgender Women
Aids
Hiv